Answers are grounded in this paper and cite their sources.
Examines mortality outcomes in individuals injecting drugs and living with chronic HCV, suggesting integrated treatment strategies.
Liver-related mortality among people who inject drugs with HCV cirrhosis was low. Mainly driven by drug-related deaths, all-cause mortality was higher among individuals with untreated HCV infection and among those with liver cirrhosis, underscoring the need for strategies that integrate HCV treatment with overdose prevention and access to broader healthcare.
No takes yet. Share an insight, caveat, or question.
Pihl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: